---
id: 105
title: Viral Hepatitis Serology and Interpretation
category: clinical_syndromes
subcategory: viral_hepatitis
tags: [hepatitis, HAV, HBV, HCV, serology, HBsAg, anti-HBs, anti-HBc]
difficulty: medium
---

## Question

How is viral hepatitis serology interpreted? Use the **"HBsAg = Active, Anti-HBs = Immune, Anti-HBc = Exposure"** framework for HBV.

## Answer

### **Hepatitis B Serology Interpretation:**

| HBsAg | Anti-HBs | Anti-HBc (IgM) | Anti-HBc (Total) | Interpretation |
|-------|----------|----------------|------------------|----------------|
| **+** | **-** | **+** | **+** | **Acute HBV infection** |
| **+** | **-** | **-** | **+** | **Chronic HBV infection** |
| **-** | **+** | **-** | **+** | **Recovered from HBV** (immune) |
| **-** | **+** | **-** | **-** | **Vaccinated** (immune) |
| **-** | **-** | **-** | **+** | **Window period** OR **false positive** |
| **-** | **-** | **-** | **-** | **No infection, not vaccinated** |

### **Key HBV Markers:**

**HBsAg (Surface Antigen):**
- **Positive = Active infection** (acute or chronic)
- Persists >6 months = chronic HBV

**Anti-HBs (Surface Antibody):**
- **Positive = Immune** (recovered or vaccinated)
- Appears after HBsAg clears
- Vaccine response (if isolated anti-HBs)

**Anti-HBc (Core Antibody):**
- **Total:** Exposure to HBV (past or present)
- **IgM:** **Acute infection**
- **Isolated anti-HBc:** Window period, occult HBV, or false positive

**HBeAg/Anti-HBe:**
- **HBeAg +:** High viral replication (high infectivity)
- **Anti-HBe +:** Low viral replication (seroconversion)

**HBV DNA:**
- Quantifies viral load (for treatment decisions)

### **Hepatitis A/C Serology:**

**Hepatitis A:**
- **Anti-HAV IgM:** **Acute infection**
- **Anti-HAV IgG (Total):** Past infection or vaccination (immune)

**Hepatitis C:**
- **Anti-HCV:** Exposure to HCV (past or present) - **Cannot distinguish active from resolved**
- **HCV RNA (PCR):** **Active infection** (confirms viremia)
- **HCV genotype:** Determines treatment duration (genotype 1 most common in US)

## Key Points

### **Chronic Hepatitis B Definition:**
- **HBsAg positive >6 months**
- **HBV DNA detectable**
- Risk factors: Neonatal/childhood infection (90% become chronic), immunosuppressed

### **When to Treat Chronic HBV:**
- **HBeAg-positive:** HBV DNA >20,000 IU/mL + elevated ALT
- **HBeAg-negative:** HBV DNA >2,000 IU/mL + elevated ALT
- **Cirrhosis:** Any detectable HBV DNA
- **Treatment:** Tenofovir or entecavir (first-line)

### **Hepatitis C Treatment:**
- **All HCV RNA-positive patients** should be treated (regardless of stage)
- **Direct-acting antivirals (DAAs):** Pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir)
- **Duration:** 8-12 weeks (cure >95%)

### **Clinical Pearls:**
- **HBsAg = Active infection** (acute or chronic if >6 months)
- **Anti-HBs = Immune** (recovered or vaccinated)
- **Anti-HBc IgM = Acute HBV**
- **Isolated anti-HBc:** Window period or occult HBV
- **HCV:** Anti-HCV does NOT distinguish active from resolved â†’ **Need HCV RNA**
- **All HCV RNA+:** Treat with DAAs (cure >95%)

## Sources

- [CDC: Hepatitis B Serology Interpretation 2024]
- [AASLD: HCV Guidelines 2024]

## Media

N/A
